drugset / Trial / NCT00993070

Efficacy and Safety Study of Topical Capsaicin in Painful Diabetic Neuropathy

NCT00993070

Phase 2/3 Completed 33 enrolled Thammasat University Bangkok Drug company · collab
RandomizedCrossoverDouble-blindTreatment

Summary

Painful diabetic neuropathy is the most common cause of neuropathic pain. 0.075% topical capsaicin has been used to treat the pain, but there is no data in lower concentration. This is the efficacy and safety of 0.025% topical capsaicin in treatment of painful diabetic polyneuropathy.

Timeline

Start
2009-10
Primary completion
2011-12
Completion
2011-12

Drugs

EvaluationDrugModalityDoseRoute
Subject Capsaicin Small molecule 0.025 % Topical